Isibikezelo Semakethe Yokwelapha Nge-Radioimmunotherapy Esinomphumela Ongaba Khona kanye Nobubanzi Bekusasa, Ithola i-FMI 2022 - 2027

Umdlavuza uyimbangela yokufa okuhamba phambili emhlabeni wonke kanti kulindeleke ukuthi ukhuphuke njengoba kulinganiselwa ezigidini ezingu-11.5 ukufa kwabantu ngo-2030. Umdlavuza ovame kakhulu umdlavuza wamaphaphu, uhlanganisa ukufa kwabantu abayizigidi ezingu-1.59, ezinye izinhlobo zomdlavuza zihlanganisa umdlavuza wesibindi, umdlavuza webele, umdlavuza wesisu, umdlavuza wesibindi, njll. Umdlavuza ungelashwa ngokuhlinzwa, ngokwelashwa ngamakhemikhali, ngokwelashwa ngemisebe, ukwelashwa ngamahomoni, ukwelashwa okuhlosiwe, imithi enembile, i-immunotherapy kanye nokufakelwa kwe-stem cell. I-Immunotherapy ihilela ukusetshenziswa kwamasosha omzimba womuntu ukulwa nomdlavuza; kuhilela ukugqugquzelwa kwamasosha omzimba ukuze ahlasele amangqamuzana omdlavuza noma anikeze amasosha omzimba amasosha omzimba enziwe umuntu.

Izinhlobo ezahlukene ze-immunotherapy zihlanganisa amasosha omzimba e-monoclonal, aklanyelwe ukuhlasela amangqamuzana athile; ama-immune checkpoint inhibitors, izidakamizwa eziqaphela futhi zihlasele amangqamuzana omdlavuza ngokukhipha amabhuleki e-T cell; imithi yokugomela umdlavuza, esetshenziselwa ukuqalisa ukusabela komzimba ngokumelene nesifo esithile kanye nokunye okuhlukahlukene okungaqondile kwe-immunotherapy isetshenziselwa ukuqinisa amasosha omzimba. I-Radioimmunotherapy iyinhlanganisela yokwelapha ngemisebe kanye ne-immunotherapy. I-Monoclonal antibody yakhiwe elabhorethri futhi ibhangqwe nento ekhipha imisebe ebizwa ngokuthi ama-radiotracers. Lapho ujovwa, umsakazo wawubhala ukuthi i-antibody ukuze ibophezele engqamuzaneni ethile yomdlavuza futhi yabhubhisa ingqamuzana lomdlavuza ngomsakazo wayo. Ama-radioactive agents asetshenziswa ngokuyinhloko yi-Yttrium-90 Ibritumomab Tiuxetan, i-Iodine-131 Tositumomab, namanye.

Ukuze uhlale 'phambi' kwezimbangi zakho, cela a Ibhukwana: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3701

Izivivinyo ezimbalwa zomtholampilo ziyaqhubeka ukuthola amandla omsakazo abhalwe ukuthi i-monoclonal antibody. I-Radioimmunotherapy iphinde isetshenziselwe ukwelapha iziguli ezine-non-Hodgkin B-cell lymphoma, nezinye izinhlobo ezincane ze-lymphoma noma iziguli ezingaphenduli ku-chemotherapy. Ngokuvamile, akukho miphumela emibi ibonakala ngesikhathi sokwelashwa. Emkhakheni wezokwelapha, izifundo zomtholampilo zenziwa ukuze kuthuthukiswe ukusebenza kahle kwebhayoloji namakhemikhali kanye nokuthuthukiswa kwenqubo yokwelashwa ku-radioimmunotherapy. Zombili izindlela eziqondile nezingaqondile zisetshenziswa ekulethweni kwama-molecule e-radioimmunotherapy. Ukwenyusa uxhaso lokuzibonela locwaningo lomdlavuza nguhulumeni kanye nezinhlaka zikahulumeni, ukwanda kokumbozwa kweMedicare, ukwanda komdlavuza phakathi kwabantu abakhulayo, ukutholakala kokwelashwa okusha komdlavuza, nezinye izici ezahlukahlukene kuzothuthukisa imakethe ye-radioimmunotherapy maduze nje.

I-Radioimmunotherapy Treatment Market: Abashayeli Nezivimbelo

Ngokusho kwe-Word Health Organization, kulinganiselwa ukuthi ngo-2030, cishe izigidi ezingu-23.6 zabantu abasha abanesifo somdlavuza bazobe sebegcwele emhlabeni jikelele. Imihlahlandlela kahulumeni evela ku-American Society of Clinical Oncology kanye ne-National Comprehensive Cancer Network (NCCN/ASCO) ihlinzeka ngosizo kochwepheshe bezempilo ekulawuleni nasekwelapheni iziguli ezinomdlavuza. Ucwaningo olujulile kanye nentuthuko kwezokwelapha umdlavuza, ukwanda kwezehlakalo zamacala omdlavuza, kwanda ukukhetha ocwaningweni lomdlavuza. Ngo-April 2016, uHulumeni wase-US wabele US$5.2 Bn for the National Cancer Institute (NCI), isikhungo sikahulumeni wobumbano, ucwaningo kanye nokuqeqeshwa umdlavuza. Isabelomali senyuke ngo-5.3% uma kuqhathaniswa nonyaka odlule. Ukufakwa komshwalense kanye nezinkinga zembuyiselo, izinkampani ezinkulu zifaka imali eningi ekwelashweni komdlavuza okubandakanya isikhathi nemali, futhi asikho isiqiniseko sokuthi umkhiqizo uzothola ukumbozwa, ubungozi bemisebe kochwepheshe bezempilo kanye neziguli ezinye zezinto ezingehlisa ukukhula komsakazo. -Immunotherapy emakethe

I-Radioimmunotherapy Treatment Market: Uhlolojikelele

Ngokusekelwe ohlotsheni lwezidakamizwa, umhlaba wonke Imakethe yokwelashwa kwe-radioimmunotherapy ihlukaniswe yaba i-ibritumomab, i-tositumomab, i-rituximab, i-epratuzumab, i-lintuzumab, i-labetuzumab ne-trastuzumab. Ngokwesisekelo sohlobo lwenqubo imakethe yokwelashwa kwe-radioimmunotherapy ihlukaniswe yaba yindlela eqondile nengaqondile. O Ngokwesisekelo senkomba yesifo, imakethe ihlukaniswe yaba i-non-hodgkin lymphoma, i-myeloid leukemia, umdlavuza we-colorectal, umdlavuza webele, i-myeloma eminingi nabanye. Ngokusekelwe kubasebenzisi bokugcina, imakethe ihlukaniswe yaba yizibhedlela, izikhungo zokuhlinza iziguli kanye nezikhungo zocwaningo lomdlavuza. Ukwenyuka kwenani leziguli ezinomdlavuza, uxhaso yizinhlaka zikahulumeni, kugxile ekuthengeni nasekuhlanganisweni ngabakhiqizi abahlukahlukene ababalulekile kubangelwa ukukhula kwemakethe yokwelashwa kwe-radio-immunotherapy.

I-Radioimmunotherapy Treatment Market: Ukubuka konke Kwesifunda

Ngokuhlakanipha kwesifunda, iMakethe ye-Radioimmunotherapy Treatment Market yomhlaba wonke ihlukaniswa ngezifunda okungukuthi, iNyakatho Melika, iLatin America, iNtshonalanga Yurophu, iMpumalanga Yurophu, i-Asia-Pacific, iJapan, iMiddle East kanye ne-Afrika. Ngaphezu kwamaphesenti angama-70 abantu ababulawa umdlavuza emhlabeni kwenzeka e-Afrika, e-Asia naseNingizimu Melika. Cishe u-33% wabantu abaphethwe umdlavuza emhlabeni wonke kungenxa yentuthu nogwayi. Kanye nokwanda kwezimakethe ezisafufusa, nokugxila kakhulu ekuxilongweni kusenesikhathi, ukuhlolwa, ukuqapha kanye nentuthuko yomtholampilo ehambisana nokwelashwa nge-radiotherapy kube amasu amakhulu amukelwa abadlali abakhulu emakethe yomhlaba wonke yokwelapha nge-radioimmunotherapy.

I-Radioimmunotherapy Treatment Market: Abadlali Ababalulekile

Abanye babadlali ababalulekile eMakethe Yokwelapha Yokwelapha Nge-Radioimmunotherapy yi-GlaxoSmithKline plc. Bayer AG, MabVax Therapeutics Holdings, Inc., Panacea Pharmaceuticals, Inc. Nordic Nanovector, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Spectrum Pharmaceuticals, Inc.kanye nabanye.

Umbiko wocwaningo wethula ukuhlola okuphelele kwemakethe futhi uqukethe imininingwane ecatshangelwayo, amaqiniso, idatha yomlando, kanye nedatha yemakethe esekelwe ngokwezibalo kanye neqinisekiswe yimboni. Iqukethe nokuqagela kusetshenziswa isethi efanelekile yokuqagela kanye nezindlela. Umbiko wocwaningo uhlinzeka ngokuhlaziywa kanye nolwazi ngokuya ngezigaba ezifana nezigaba zemakethe, izindawo, uhlobo lomkhiqizo kanye nezicelo.

Umbiko uhlanganisa ukucazululwa okuphelele kwi:

• Izigaba Zemakethe
• Amandla weMakethe
• Ubukhulu bemakethe
• Ukuthengisela & Isidingo
• Amathrendi/Izinkinga/Izinselele zamanje
• Ukuncintisana Nezinkampani ezihilelekile
• Ubuchwepheshe
• I-Value Chain

Ukuhlaziywa kwesifunda kuhlanganisa

• I-North America (US, Canada)
• I-Latin America (iMexico, iBrazil kanye ne-Latin America yonke)
• I-Western Europe (iJalimane, i-Italy, i-France, i-UK, i-Spain, amazwe ase-Nordic, i-Belgium, i-Netherlands, i-Luxembourg kanye ne-Western Europe yonke)
• I-Eastern Europe (iPoland, iRussia kanye nayo yonke iMpumalanga Yurophu)
• I-Asia Pacific (China, India, ASEAN, Australia neNew Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, and Rest of MEA)

Lo mbiko uyinhlanganisela yolwazi lokuqala, ukuhlolwa kwekhwalithi kanye nomthamo okwenziwa abahlaziyi bezimboni, imibono evela kochwepheshe bemboni nabahlanganyeli bemboni kulo lonke uchungechunge lwenani. Lo mbiko uhlinzeka ngokuhlaziywa okujulile kokuthambekela kwemakethe yabazali, izinkomba zomnotho omkhulu kanye nezici ezibusayo kanye nokukhanga kwemakethe ngokwezigaba. Umbiko uphinde wenze imephu umthelela wekhwalithi wezinto ezihlukene zemakethe ezigabeni zemakethe kanye nezindawo

I-Radioimmunotherapy Treatment Market: Ukuhlukaniswa

Imakethe yomhlaba wonke yokwelapha nge-radioimmunotherapy ihlukaniswe ngesisekelo sohlobo lwezidakamizwa, uhlobo lwenqubo, inkomba yesifo, uhlobo oluqondiwe kanye nendawo.

Ngokusekelwe ohlotsheni lwezidakamizwa, imakethe yokwelashwa kwe-radioimmunotherapy ihlukaniswe yaba okulandelayo:

• I-Ibritumomab
• I-Tositumomab
• I-Rituximab
• Epratuzumab
• Lintuzumab
• Labetuzumab
• I-Trastuzumab
• Abanye

Ngokusekelwe Ohlotsheni Lwenqubo, imakethe yokwelashwa kwe-radioimmunotherapy yomhlaba wonke ihlukaniswe yaba okulandelayo:

• Indlela Eqondile
• Indlela engaqondile

Ngokusekelwe kuNkomba Yezifo, imakethe yomhlaba wonke yokwelapha nge-radioimmunotherapy ihlukaniswe yaba okulandelayo:

• I-non-Hodgkin lymphoma
• Umdlavuza wegazi we-Myeloid
• umdlavuza Colorectal
• Breast Cancer
• I-Myeloma eminingi
• Abanye

Ngokusekelwe kuMsebenzisi Wokugcina, imakethe yokwelashwa kwe-radioimmunotherapy yomhlaba ihlukaniswe yaba okulandelayo:

• Izibhedlela
• Izikhungo zokuhlinza iziguli
• Izikhungo Zokucwaninga Ngomdlavuza
• Abanye

Ukuze uqhubekele phambili, thola i-TOC yalo Mbiko:  https://www.futuremarketinsights.com/toc/rep-gb-3701

Bika amaphuzu avelele:

• Uhlolojikelele olunemininingwane yemakethe yomzali
• Ukushintsha amandla emakethe embonini
• Ukuhlukaniswa kwemakethe okujulile
• Usayizi wemakethe, wamanje noweqanjiwe ngokuya ngevolumu nenani
• Izitayela nentuthuko yakamuva yemboni
• Indawo yokuncintisana
• Amasu abadlali ababalulekile nemikhiqizo ehlinzekwayo
• Amasegimenti angenzeka kanye ne-niche, izifunda zezwe ezibonisa ukukhula okuthembisayo
• Umbono ongathathi hlangothi ekusebenzeni kwemakethe
• Okufanele ube nolwazi lwabadlali bemakethe ukuze basekele futhi bathuthukise indawo yabo yemakethe

Mayelana ne-Future Market Insights (FMI)
I-Future Market Insights (FMI) ingumhlinzeki oholayo wezobunhloli bemakethe nezinsizakalo zokubonisana, esebenzela amaklayenti emazweni angaphezu kuka-150. I-FMI izinze e-Dubai, futhi inezikhungo zokulethwa kwezidingo e-UK, US nase-India. Imibiko yakamuva yocwaningo lwemakethe ye-FMI kanye nokuhlaziywa kwemboni kusiza amabhizinisi ukuthi abheke izinselele futhi enze izinqumo ezibucayi ngokuzethemba nokucaca phakathi kokuncintisana okungapheli. Imibiko yethu yocwaningo lwemakethe eyenziwe ngokwezifiso nehlanganisiwe iletha imininingwane ebambekayo eqhuba ukukhula okuzinzile. Ithimba labahlaziyi abaholwa ochwepheshe kwa-FMI lilandelela ngokuqhubekayo amathrendi nemicimbi evelayo ezinhlobonhlobo zezimboni ukuze liqinisekise ukuthi amakhasimende ethu alungiselela izidingo eziguqukayo zabathengi bawo.

Xhumana nathi:
Imininingwane Yasemakethe Yesikhathi Esizayo
Iyunithi Cha: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
IJumeirah Lakes Towers, eDubai,
I-United Arab Emirates
Ngemibuzo yokuthengisa: [i-imeyili ivikelwe]
Ngemibuzo Yemidiya: [i-imeyili ivikelwe]
Iwebhusayithi: https://www.futuremarketinsights.com